The effects of Nocturnal Haemodialysis (NHD) compared to conventional haemodialysis on progression of Left Ventricular (LV) mass: a randomised controlled pilot study

Completed

• Conditions: End-stage kidney disease; Urological and Genital Diseases; Renal disease

• Registration Number: ISRCTN25858715
• Lead Sponsor: Kidney Foundation of Canada (Canada)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2004-10-19
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 38

Inclusion Criteria

All adult haemodialysis patients in Alberta, Canada are eligible.

Exclusion Criteria

Patients who are unable to perform NHD due to physical or mental incapacity.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in left ventricular mass (measured by CMR) at 6 months.

Secondary Outcome Measures

Name	Time	Method
1. Mean change in systolic Blood Pressure (BP)<br>2. Change in HRQOL (Health-Related Quality-Of-Life)<br>3. Mean change in Haematocrit (Hct)/Erythropoietin (Epo) ratio<br>4. Mean change in calcium - phosphorus product